Atika Capital Management »

Tarsus Pharmaceuticals shares owned by Atika Capital Management

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 40k 62.94
2025-03-31 $7.4M 144k 51.37
2024-12-31 $9.8M 177k 55.37

More positions owned by Atika Capital Management

Alkermes SHS Call Option (ALKS)
Vertiv Holdings Com Cl A (VRT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Seagate Technology Hldngs Pl Ord Shs (STX)
Ge Vernova Put Option (GEV)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Intel Corporation (INTC)
Micron Technology Put Option (MU)
Echostar Corp Cl A
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Guardant Health (GH)
Ishares Tr Expanded Tech Put Option (IGV)
Ciena Corp Com New (CIEN)

View all positions for Atika Capital Management

Top funds holding Tarsus Pharmaceuticals

BlackRock
Deep Track Capital
Rtw Investments
Jupiter Topco
Paradigm Biocapital Advisors
Henderson Group
Morgan Stanley
Vanguard Capital Management
Jennison Associates
Tang Capital Management
Millennium Management
Bank of America Corporation
Geode Capital Management
Vestal Point Capital
State Street Corporation

View all funds holding Tarsus Pharmaceuticals